Infliximab does not lead to reduction in the interferon-gamma and lymphoproliferative responses of patients with moderate to severe psoriasis
Ortigosa, Luciena C M, Silva, Léia C R, Duarte, Alberto J S, Takahashi, Maria D F, Benard, Gil
Published in Acta dermato-venereologica (01.01.2014)
Published in Acta dermato-venereologica (01.01.2014)
Get full text
Journal Article